30 employees
TaiMed Biologics is a biotechnology company that develops monoclonal antibody therapeutics for HIV disease.
2007
$22M
from 1 investors over 1 rounds
TaiMed Biologics Inc raised $22M on March 31, 2010
Investors: YFY Biotech Management Company / Taiwan Global BioFund